|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lordick F, Allum W, Carneiro F, Mitry E,
Tabernero J, Tan P, Van Cutsem E, van de Velde C and Cervantes A:
Unmet needs and challenges in gastric cancer: The way forward.
Cancer Treat Rev. 40:692–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
SR A, Cervantes A and van de Velde CJ:
Gastric cancer: Epidemiology, pathology and treatment. Ann Oncol.
14(Suppl 2): ii31–ii36. 2003.
|
|
4
|
Falcone A: Future strategies and adjuvant
treatment of gastric cancer. Ann Oncol. 14(Suppl 2): ii45–ii47.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ang SD: Gastric cancer surgery: Can east
meet west? J Surg Oncol. 102:7362010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krejs GJ: Gastric cancer: Epidemiology and
risk factors. Dig Dis. 28:600–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li W, Qin J, Sun YH and Liu TS:
Neoadjuvant chemotherapy for advanced gastric cancer: A
meta-analysis. World J Gastroenterol. 16:5621–5628. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahn HS, Lee HJ, Yoo MW, Jeong SH, Park DJ,
Kim HH, Kim WH, Lee KU and Yang HK: Changes in clinicopathological
features and survival after gastrectomy for gastric cancer over a
20-year period. Br J Surg. 98:255–260. 2011. View Article : Google Scholar
|
|
9
|
Park BS, Son DJ, Park YH, Kim TW and Lee
SE: Antiplatelet effects of acidamides isolated from the fruits of
Piper longum L. Phytomedicine. 14:853–855. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang YC, Lee SG, Lee HK, Kim MK, Lee SH
and Lee HS: A piperidine amide extracted from Piper longum L. fruit
shows activity against Aedes aegypti mosquito larvae. J Agr Food
Chem. 50:3765–3767. 2002. View Article : Google Scholar
|
|
11
|
Son DJ, Kim SY, Han SS, Kim CW, Kumar S,
Park BS, Lee SE, Yun YP, Jo H and Park YH: Piperlongumine inhibits
atherosclerotic plaque formation and vascular smooth muscle cell
proliferation by suppressing PDGF receptor signaling. Biochem Bioph
Res Commun. 427:349–354. 2012. View Article : Google Scholar
|
|
12
|
Bang JS, Oh da H, Choi HM, Sur BJ, Lim SJ,
Kim JY, Yang HI, Yoo MC, Hahm DH and Kim KS: Anti-inflammatory and
antiarthritic effects of piperine in human interleukin
1beta-stimulated fibroblast-like synoviocytes and in rat arthritis
models. Arthritis Res Ther. 11:R492009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fontenele JB, Leal L, Silveira ER, Felix
FH, Bezerra Felipe CF and Viana GS: Antiplatelet effects of
piplartine, an alkamide isolated from Piper tuberculatum: Possible
involvement of cyclooxygenase blockade and antioxidant activity. J
Pharm Pharmacol. 61:511–515. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsai IL, Lee FP, Wu CC, Duh CY, Ishikawa
T, Chen JJ, Chen YC, Seki H and Chen IS: New cytotoxic
cyclobutanoid amides, a new furanoid lignan and anti-platelet
aggregation constituents from Piper arborescens. Planta Med.
71:535–542. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wakade AS, Shah AS, Kulkarni MP and
Juvekar AR: Protective effect of Piper longum L. on oxidative
stress induced injury and cellular abnormality in adriamycin
induced cardiotoxicity in rats. Indian J Exp Biol. 46:528–533.
2008.PubMed/NCBI
|
|
16
|
Cícero Bezerra Felipe F, Trajano Sousa
Filho J, de Oliveira Souza LE, Alexandre Silveira J, Esdras de
Andrade Uchoa D, Rocha Silveira E, Deusdênia Loiola Pessoa O and de
Barros Viana GS: Piplartine, an amide alkaloid from Piper
tuberculatum, presents anxiolytic and antidepressant effects in
mice. Phytomedicine. 14:605–612. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vedhanayaki G, Shastri GV and Kuruvilla A:
Analgesic activity of Piper longum Linn. root. Indian J Exp Biol.
41:649–651. 2003.
|
|
18
|
Randhawa H, Kibble K, Zeng H, Moyer M and
Reindl K: Activation of ERK signaling and induction of colon cancer
cell death by piperlongumine. Toxicol In Vitro. 27:1626–1633. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dhillon H, Chikara S and Reindl KM:
Piperlongumine induces pancreatic cancer cell death by enhancing
reactive oxygen species and DNA damage. Toxicol Rep. 1:309–318.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gong LH, Chen XX, Wang H, Jiang QW, Pan
SS, Qiu JG, Mei XL, Xue YQ, Qin WM and Zheng FY: Piperlongumine
induces apoptosis and synergizes with cisplatin or paclitaxel in
human ovarian cancer cells. Oxid Med Cell Longev. 2014:9068042014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Jackson C, Judd LM, Menheniott T, Kronborg
I, Dow C, Yeomans ND, Boussioutas A, Robb L and Giraud A: Augmented
gp130-mediated cytokine signalling accompanies human gastric cancer
progression. J Pathol. 213:140–151. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanda N, Seno H, Konda Y, Marusawa H,
Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y,
et al: STAT3 is constitutively activated and supports cell survival
in association with survivin expression in gastric cancer cells.
Oncogene. 23:4921–4929. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heinrich P, Behrmann I, Haan S, Hermanns
HM, Müller-Newen G and Schaper F: Principles of interleukin
(IL)-6-type cytokine signalling and its regulation. Biochem J.
374:1–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Böger C, Behrens HM and Röcken C: Ki67 -
an unsuitable marker of gastric cancer prognosis unmasks
intratumoral heterogeneity. J Surg Oncol. 113:46–54. 2016.
View Article : Google Scholar
|
|
26
|
Wang Y, Zhou X, Shan B, Han J, Wang F, Fan
X, Lv Y, Chang L and Liu W: Downregulation of microRNA-33a promotes
cyclin dependent kinase 6, cyclin D1 and PIM1 expression and
gastric cancer cell proliferation. Mol Med Rep. 12:6491–6500.
2015.PubMed/NCBI
|
|
27
|
Gao XH, Yang XQ, Wang BC, Liu SP and Wang
FB: Overexpression of twist and matrix metalloproteinase-9 with
metastasis and prognosis in gastric cancer. Asian Pac J Cancer
Prev. 14:5055–5060. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jatiani SS, Baker SJ, Silverman LR and
Reddy EP: JAK/STAT pathways in cytokine signaling and
myeloproliferative disorders: Approaches for targeted therapies.
Genes Cancer. 1:979–993. 2010. View Article : Google Scholar
|
|
29
|
Wu H, Huang M, Cao P, Wang T, Shu Y and
Liu P: MiR-135a targets JAK2 and inhibits gastric cancer cell
proliferation. Cancer Biol Ther. 13:281–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,2/STAT3
signaling induces apoptosis, cell cycle arrest and reduces tumor
cell invasion in colorectal cancer cells. Neoplasia. 10:287–297.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ingley E and Klinken SP: Cross-regulation
of JAK and Src kinases. Growth Factors. 24:89–95. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Akira S: Roles of STAT3 defined by
tissue-specific gene targeting. Oncogene. 19:2607–2611. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Avalle L, Pensa S, Regis G, Novelli F and
Poli V: STAT1 and STAT3 in tumorigenesis: A matter of balance.
JAKSTAT. 1:65–72. 2012.PubMed/NCBI
|
|
34
|
Chang Q, Bournazou E, Sansone P, Berishaj
M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, et al:
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and
metastasis. Neoplasia. 15:848–862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mukhopadhyay A1, Banerjee S, Stafford LJ,
Xia C, Liu M and Aggarwal BB: Curcumin-induced suppression of cell
proliferation correlates with down-regulation of cyclin D1
expression and CDK4-mediated retinoblastoma protein
phosphorylation. Oncogene. 21:8852–8861. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Weinstein IB: Disorders in cell circuitry
during multistage carcinogenesis: the role of homeostasis.
Carcinogenesis. 21:857–864. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu LF, Zhu YB, Qiao MM, Zhong J, Tu SP and
Wu YL: Constitutive activation and clinical significance of Stat3
in human gastric cancer tissues and cell lines. Chin Med J.
84:2064–2069. 2004.In Chinese.
|
|
38
|
Judd LM, Menheniott TR, Ling H, Jackson
CB, Howlett M, Kalantzis A, Priebe W and Giraud AS: Inhibition of
the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and
in vivo. PloS One. 9:e959932014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim MJ, Nam HJ, Kim HP, Han SW, Im SA, Kim
TY, Oh DY and Bang YJ: OPB–31121, a novel small molecular
inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an
antitumor activity in gastric cancer cells. Cancer Lett.
335:145–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khanna P, Chua PJ, Bay BH and Baeg GH: The
JAK/STAT signaling cascade in gastric carcinoma (Review). Int J
Oncol. 47:1617–1626. 2015.PubMed/NCBI
|
|
41
|
Huang W, Yu LF, Zhong J, Wu W, Zhu JY,
Jiang FX and Wu YL: Stat3 is involved in angiotensin II-induced
expression of MMP2 in gastric cancer cells. Dig Dis Sci.
54:2056–2062. 2009. View Article : Google Scholar
|
|
42
|
Tactacan CM, Phua YW, Liu L, Zhang L,
Humphrey ES, Cowley M, Pinese M, Biankin AV and Daly RJ: The
pseudokinase SgK223 promotes invasion of pancreatic ductal
epithelial cells through JAK1/Stat3 signaling. Mol Cancer.
14:139–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
